Who owns Trius Therapeutics?
Key information on Trius Therapeutics (Ticker: TSRX)
Who owns Trius Therapeutics?
Is TSRX a good stock to own? Find out who bought Trius Therapeutics, who sold Trius Therapeutics (TSRX) stock, and who holds a large position in Trius Therapeutics.
- Wellington Management Company owns 2.70M shares worth $18.49M
- First Eagle Investment Management owns 1.79M shares worth $12.28M
- Broadfin Capital owns 1.21M shares worth $5.79M
- Sectoral Asset Management owns 1.00M shares worth $5.85M
- Vanguard owns 997366 shares worth $6.82M
- Perceptive Advisors owns 920996 shares worth $6.59M
- Thomas Weisel Asset Management owns 782942 shares worth $3.74M
- Technical Financial Services owns 782278 shares worth $5.35M
- Redmile owns 778250 shares worth $5.32M
- Ayer Capital Management owns 509165 shares worth $2.72M
- CI Investments owns 427097 shares worth $2.46M
- AXA owns 425846 shares worth $2.91M
- STATE STREET CORPORATION owns 386101 shares worth $2.64M
- Timberline Asset Management owns 380383 shares worth $2.60M
- Callan Capital owns 318096 shares worth $2.22M
- BBT Capital Management owns 300931 shares worth $1.73M
- Manatuck Hill Partners owns 285000 shares worth $2.04M
- Shott Capital Management owns 239233 shares worth $1.28M
- Millennium Management owns 238345 shares worth $1.63M
- Alyeska Investment owns 227500 shares worth $1.31M
- Heather K. Mellem, Esq. owns 214639 shares worth $1.47M
- Balyasny Asset Management owns 213000 shares worth $1.46M
- GRT Capital Partners owns 211222 shares worth $1.44M
- Diamondback Capital Management owns 203200 shares worth $1.18M
- Dr. Jeffrey R. Jay, M.D owns 200000 shares worth $1.15M
- SMITH ASSET MANAGEMENT owns 189438 shares worth $905.51M
- Eudaimonia Asset Management owns 166613 shares worth $1.14M
- Credit Suisse AG owns 163888 shares worth $1.12M
- PanAgora Asset Management owns 161907 shares worth $773915
- TIAA-CREF Investment Management owns 153344 shares worth $1.05M
- Renaissance Technologies owns 148071 shares worth $852888
- Schroder Investment Management owns 144929 shares worth $991314
- Geode Capital Management owns 143619 shares worth $982353
- Frank Russell Company owns 141378 shares worth $948646
- Polar Capital owns 135899 shares worth $928190
- Bridgeway Capital Management owns 126700 shares worth $605626
- T. Rowe Price Associates owns 120000 shares worth $820800
- D. E. Shaw & Co owns 104279 shares worth $713268
- Ellington Management owns 92200 shares worth $630648
- Jacob Asset Management of New York owns 85000 shares worth $581400
- OrbiMed Advisors owns 81600 shares worth $437376
- NUMERIC INVESTORS owns 79288 shares worth $542329
- Two Sigma Investments owns 74971 shares worth $401844
Who sold Trius Therapeutics?
- Bank of America Corporation sold on June 30, 2012
Funds that own TSRX also own:
- Teva Pharmaceutical Industries (TEVA)
- Vertex Pharmaceuticals Incorporated (VRTX)
- Cardinal Health (CAH)
- Bristol Myers Squibb (BMY)
- WellCare Health Plans (WCG)
- McKesson Corporation (MCK)
- Allergan (AGN)
- Intuitive Surgical (ISRG)
- Gilead Sciences (GILD)
- Array BioPharma (ARRY)
- Onyx Pharmaceuticals (ONXX)
- Exelixis (EXEL)
- Salix Pharmaceuticals (SLXP)
- Celgene Corporation (CELG)
- Elan Corporation (ELN)
- Neurocrine Biosciences (NBIX)
- NuVasive (NUVA)
- Idenix Pharmaceuticals (IDIX)
- St. Jude Medical (STJ)
- HeartWare International (HTWR)
- Trius Therapeutics (TSRX)